NRX Pharmaceuticals Inc. 于7月21日在提交给美国证券交易委员会的文件中披露,其已获得美国国防高级研究计划局的遴选,将就一项潜在的SPARC-TMS临床试验资助项目展开谈判。
NRX Pharmaceuticals Inc. 于7月21日在提交给美国证券交易委员会的文件中披露,其已获得美国国防高级研究计划局的遴选,将就一项潜在的SPARC-TMS临床试验资助项目展开谈判。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.